tiprankstipranks
Trending News
More News >
Medistim ASA (DE:MD1)
FRANKFURT:MD1
Germany Market
Advertisement

Medistim ASA (MD1) Ratios

Compare
1 Followers

Medistim ASA Ratios

DE:MD1's free cash flow for Q2 2025 was kr0.82. For the 2025 fiscal year, DE:MD1's free cash flow was decreased by kr and operating cash flow was kr0.33. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.14 4.15 3.87 3.95 4.13
Quick Ratio
1.73 2.61 2.72 2.69 2.24
Cash Ratio
0.78 1.63 1.44 1.61 1.11
Solvency Ratio
1.04 1.18 1.14 1.11 0.96
Operating Cash Flow Ratio
1.22 1.20 1.14 1.65 1.25
Short-Term Operating Cash Flow Coverage
16.20 0.00 0.00 -1.76 7.50
Net Current Asset Value
kr 236.84Mkr 283.79Mkr 270.93Mkr 209.31Mkr 156.81M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.03 0.04 0.06 0.11
Debt-to-Equity Ratio
0.06 0.04 0.05 0.08 0.15
Debt-to-Capital Ratio
0.05 0.04 0.04 0.07 0.13
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.03
Financial Leverage Ratio
1.39 1.27 1.31 1.32 1.35
Debt Service Coverage Ratio
7.73 215.90 1.07K -1.50 8.58
Interest Coverage Ratio
14.47 229.39 1.15K 653.25 654.01
Debt to Market Cap
<0.01 0.00 0.00 -0.01 <0.01
Interest Debt Per Share
1.85 0.99 0.94 1.34 2.16
Net Debt to EBITDA
-0.36 -0.88 -0.78 -0.76 -0.25
Profitability Margins
Gross Profit Margin
72.80%78.45%78.10%76.76%78.50%
EBIT Margin
28.09%25.22%30.11%27.44%26.81%
EBITDA Margin
32.17%29.76%33.68%31.60%30.40%
Operating Profit Margin
26.96%25.22%29.05%27.83%26.81%
Pretax Profit Margin
27.10%25.95%30.04%27.30%25.72%
Net Profit Margin
20.67%19.92%23.44%21.76%19.48%
Continuous Operations Profit Margin
20.67%19.92%23.44%21.76%19.48%
Net Income Per EBT
76.25%76.79%78.04%79.69%75.74%
EBT Per EBIT
100.54%102.87%103.40%98.10%95.94%
Return on Assets (ROA)
24.51%20.53%23.61%22.54%20.06%
Return on Equity (ROE)
31.00%26.09%31.00%29.70%27.01%
Return on Capital Employed (ROCE)
41.59%31.95%36.90%35.71%33.35%
Return on Invested Capital (ROIC)
31.01%24.04%28.27%35.64%23.63%
Return on Tangible Assets
28.60%22.55%25.52%24.37%22.16%
Earnings Yield
2.75%2.65%2.70%1.36%1.52%
Efficiency Ratios
Receivables Turnover
5.41 7.01 4.78 5.68 6.20
Payables Turnover
0.00 4.48 4.35 7.35 5.66
Inventory Turnover
0.99 0.77 0.93 1.00 0.68
Fixed Asset Turnover
9.02 9.09 9.48 7.10 5.51
Asset Turnover
1.19 1.03 1.01 1.04 1.03
Working Capital Turnover Ratio
2.07 1.79 1.89 2.01 2.07
Cash Conversion Cycle
436.18 443.14 384.33 380.72 531.43
Days of Sales Outstanding
67.52 52.04 76.31 64.22 58.90
Days of Inventory Outstanding
368.66 472.64 391.90 366.12 537.02
Days of Payables Outstanding
0.00 81.54 83.88 49.63 64.49
Operating Cycle
436.18 524.68 468.20 430.35 595.92
Cash Flow Ratios
Operating Cash Flow Per Share
8.25 6.18 6.22 7.03 4.07
Free Cash Flow Per Share
8.25 4.56 5.06 6.40 3.49
CapEx Per Share
0.00 1.62 1.16 0.63 0.58
Free Cash Flow to Operating Cash Flow
1.00 0.74 0.81 0.91 0.86
Dividend Paid and CapEx Coverage Ratio
1.37 1.01 1.27 1.94 1.22
Capital Expenditure Coverage Ratio
0.00 3.81 5.38 11.16 6.97
Operating Cash Flow Coverage Ratio
6.84 6.42 6.63 5.30 1.90
Operating Cash Flow to Sales Ratio
0.24 0.22 0.23 0.31 0.21
Free Cash Flow Yield
3.15%2.13%2.19%1.74%1.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
36.33 37.74 36.98 73.65 65.58
Price-to-Sales (P/S) Ratio
7.53 7.52 8.67 16.02 12.77
Price-to-Book (P/B) Ratio
12.41 9.85 11.46 21.87 17.72
Price-to-Free Cash Flow (P/FCF) Ratio
31.73 46.95 45.62 57.39 71.66
Price-to-Operating Cash Flow Ratio
31.62 34.62 37.14 52.24 61.38
Price-to-Earnings Growth (PEG) Ratio
5.42 -4.07 1.46 2.38 -42.30
Price-to-Fair Value
12.41 9.85 11.46 21.87 17.72
Enterprise Value Multiple
23.05 24.39 24.96 49.94 41.78
Enterprise Value
4.71B 3.78B 4.09B 6.59B 4.52B
EV to EBITDA
23.05 24.39 24.96 49.94 41.78
EV to Sales
7.42 7.26 8.41 15.78 12.70
EV to Free Cash Flow
31.24 45.32 44.25 56.52 71.24
EV to Operating Cash Flow
31.24 33.42 36.02 51.46 61.02
Tangible Book Value Per Share
16.83 19.25 18.17 15.15 12.32
Shareholders’ Equity Per Share
21.03 21.73 20.15 16.80 14.11
Tax and Other Ratios
Effective Tax Rate
0.24 0.23 0.22 0.20 0.24
Revenue Per Share
34.76 28.46 26.65 22.94 19.57
Net Income Per Share
7.18 5.67 6.25 4.99 3.81
Tax Burden
0.76 0.77 0.78 0.80 0.76
Interest Burden
0.96 1.03 1.00 0.99 0.96
Research & Development to Revenue
0.05 0.03 0.03 0.03 0.04
SG&A to Revenue
0.00 0.28 0.06 0.07 0.07
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.06 1.09 1.00 1.41 1.07
Currency in NOK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis